Experimental Drug Targets COVID-19 From Two Angles
(Reuters) – An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions, […]
Read more(Reuters) – An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions, […]
Read moreJOHANNESBURG (Reuters) – Unvaccinated people infected with the Omicron variant of coronavirus may be less prone to severe illness and requiring hospital care or dying […]
Read moreLorraine: Dr Amir says spine could shrink if deficient in vitamin D We use your sign-up to provide content in ways you’ve consented to and […]
Read moreIndividuals living with Type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some […]
Read moreA timely new study investigated the incidence of false-positive results in a large sample of rapid antigen tests used to serially screen asymptomatic workers throughout […]
Read moreJianhan Chen, a University of Massachusetts Amherst chemistry and biochemistry and molecular biology professor, has received a five-year, $2 million National Institutes of Health (NIH) […]
Read moreDementia: Dr Sara on benefits of being in nature We use your sign-up to provide content in ways you’ve consented to and to improve our […]
Read moreThis Morning: Dr Zoe discusses carbohydrates in your diet We use your sign-up to provide content in ways you’ve consented to and to improve our […]
Read moreOmicron being called a 'mild disease' is 'incorrect' says Whitty We use your sign-up to provide content in ways you’ve consented to and to improve […]
Read moreA new investigation has found that rates of physical trauma following operative vaginal delivery (OVD) in Canada are higher than previously reported. The cohort study […]
Read more